Offer - Urjas Oil for just ₹ 1 X
Imudrops DS Eye Drop (5), a prescription drug, is manufactured in various forms such as Drops. Psoriasis, Liver transplant are some of its major therapeutic uses. Imudrops DS Eye Drop (5) also has some secondary and off-label uses. These are listed below.
The right dosage of Imudrops DS Eye Drop (5) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Imudrops DS Eye Drop (5) are Increased hair growth, Loss of appetite. Some other side effects of Imudrops DS Eye Drop (5) have been listed ahead. Such side effects of Imudrops DS Eye Drop (5) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Imudrops DS Eye Drop (5)'s effect is Unknown during pregnancy and Severe for lactating mothers. Further, the section on Imudrops DS Eye Drop (5) related warnings talks about Imudrops DS Eye Drop (5)'s effects on the liver, heart and kidney.
Imudrops DS Eye Drop (5) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Imudrops DS Eye Drop (5) in conditions like Liver Disease. Other conditions have been mentioned below in the Imudrops DS Eye Drop (5) contraindications section.
Additionally, Imudrops DS Eye Drop (5) may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Imudrops DS Eye Drop (5) is safe while driving, and is is addictive in nature.
Imudrops DS Eye Drop (5) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Imudrops DS Eye Drop (5) safe for pregnant women?
The effects of Imudrops on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Imudrops DS Eye Drop (5) safe during breastfeeding?
Imudrops should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Imudrops DS Eye Drop (5) on the Kidneys?
Imudrops may have mild side effects on the kidneys.
What is the effect of Imudrops DS Eye Drop (5) on the Liver?
Very few cases of side effects of Imudrops on the liver have been reported.
What is the effect of Imudrops DS Eye Drop (5) on the Heart?
Imudrops has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Imudrops DS Eye Drop (5) unless your doctor advises you to do so -
Is this Imudrops DS Eye Drop (5) habit forming or addictive?
No, there is no any evidence that Imudrops DS Eye Drop (5) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Imudrops DS Eye Drop (5) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Imudrops DS Eye Drop (5) only as per medical advice.
Is it able to treat mental disorders?
Imudrops DS Eye Drop (5) is unable to treat or cure mental disorders.
Interaction between Food and Imudrops DS Eye Drop (5)
Imudrops DS Eye Drop (5) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Imudrops DS Eye Drop (5)
Consuming Imudrops DS Eye Drop (5) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380